Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) is now available.
Shandong Xinhua Pharmaceutical Company Limited has proposed a final ordinary cash dividend of RMB 0.15 per share for the financial year ended 31 December 2025, subject to shareholder approval. Key details including the shareholders’ approval date, ex-dividend date, record date, payment date, currency of payment for Hong Kong shareholders, applicable exchange rate, and withholding tax treatment will be announced later, leaving investors to await further clarification on the timetable and net payout.
The announcement signals the company’s intention to return cash to shareholders, which may be viewed as a sign of operational stability and profitability for 2025. However, the absence of finalised payment logistics and tax information introduces some uncertainty for investors, particularly overseas holders, who will need to monitor subsequent disclosures to fully assess the dividend’s impact on their effective yield and cash flow planning.
The most recent analyst rating on (HK:0719) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Shandong Xinhua Pharmaceutical Company Limited Class H stock, see the HK:0719 Stock Forecast page.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a Hong Kong-listed pharmaceuticals manufacturer, operating in the healthcare and drug industry. It issues both domestic and H-shares and is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical governance structure for a sizable Chinese pharma group.
Average Trading Volume: 989,077
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.46B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.